Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advantages of Liraglutide Mediated Through Its Effect on Clock Gene mRNA Expression

NCT02783196 is registered in ClinicalTrials.gov with Tel Aviv University as lead sponsor.

NCT NCT02783196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02783196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advantages of Liraglutide Mediated Through Its Effect on Clock Gene mRNA Expression
Lead sponsor
Tel Aviv University
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2016
Completion date
June 30, 2017
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes